
|Articles|April 1, 2006
OTC: overwhelming and total confusion?
During resident clinic recently, I met an elderly woman suffering from age-related macular degeneration (AMD). Upset with 20/300 vision in her left eye, she was desperate to maintain her right eye's 20/25 vision.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA
2
Inside the clinic: Surgeon shares real-world experience
3
What changed in glaucoma care in 2025: Surgeon perspective
4
PRIMAvera study: Central vision improvement with subretinal implant
5












































